Granules India Reports Strong FY26, Q4 PAT Jumps 33% to Rs 2,016 Mn Written By Parthika Patel30 April 2026 6:26 PM ISTNew Delhi: Granules India Limited has reported strong financial performance for the quarter and financial year ended March 31, 2026, with Q4 FY26...
Alembic Secures USFDA Approval for Gilenya Generic Written By Parthika Patel27 April 2026 12:15 PM ISTVadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Fingolimod Capsules,...
Morepen Labs Clears USFDA Inspection With Zero Observations at Himachal API Facility Written By Parthika Patel23 April 2026 12:15 PM ISTNew Delhi: Morepen Laboratories Limited has successfully completed a United States Food and Drug Administration (USFDA) inspection at its API...
Aurobindo Pharma Gets USFDA Nod for Generic Ravicti to Treat Urea Cycle Disorders Written By Parthika Patel17 April 2026 4:37 PM ISTNew Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for Glycerol...
Piramal Pharma Closes USFDA Inspection at Lexington Facility with VAI Status Written By Parthika Patel13 April 2026 6:53 PM ISTNew Delhi: Piramal Pharma Limited has successfully closed the USFDA inspection at its Lexington, Kentucky manufacturing facility following the receipt...
Orbicular Pharma, Apotex Secure USFDA Tentative Nod for Generic Ozempic Written By sheeba farhat13 April 2026 6:33 PM ISTHyderabad: Orbicular Pharmaceutical Technologies on Saturday announced that a generic version of Ozempic (semaglutide injection), developed in...
Glenmark Secures USFDA Nod for Progesterone Vaginal Inserts, Targets USD 59 Million US Market Written By Parthika Patel10 April 2026 9:22 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Progesterone...
Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets Written By Parthika Patel10 April 2026 9:14 PM ISTNew Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin...
Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report Written By sheeba farhat10 April 2026 9:01 PM ISTNew Delhi: India's pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of...
Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity Written By Parthika Patel8 April 2026 9:22 PM ISTNew Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and...
USFDA Approves Alembic's Dapagliflozin Tablets, Grants 180-Day Exclusivity Written By Parthika Patel8 April 2026 8:47 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for its...
Alembic Pharma Gets USFDA Nod for Paroxetine ER Tablets Written By Parthika Patel28 March 2026 8:27 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Paroxetine...
